Browsing byAuthorKing, MT

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 38 to 49 of 49< previous 
Issue DateTitleAuthor(s)
2022-06-16The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study.McTaggart-Cowan, H; King, MT; Norman, R; Costa, DSJ; Pickard, AS; Viney, R; Peacock, SJ; Canadian MAUCa Team,
2021-06-01The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value SetKing, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Muller, F; Viney, R; Pickard, AS; Cella, D
2021-06The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set.King, MT; Norman, R; Mercieca-Bebber, R; Costa, DSJ; McTaggart-Cowan, H; Peacock, S; Janda, M; Müller, F; Viney, R; Pickard, AS; Cella, D; Multi-Attribute Utility in Cancer Consortium,
2011-01-01Time trade-off derived EQ-5D weights for AustraliaViney, R; Norman, R; King, MT; Cronin, P; Street, DJ; Knox, S; Ratcliffe, J
2019U.K. utility weights for the EORTC QLU‐C10DNorman, R; Mercieca-Bebber, R; Rowen, D; Brazier, JE; Cella, D; Pickard, AS; Street, DJ; Viney, R; King, MT
2021-05United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.Revicki, DA; King, MT; Viney, R; Pickard, AS; Mercieca-Bebber, R; Shaw, JW; Müller, F; Norman, R
2024-01United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument.King, MT; Revicki, DA; Norman, R; Müller, F; Viney, RC; Pickard, AS; Cella, D; Shaw, JW; MAUCa Consortium,
2016-03-01Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation formatNorman, R; Viney, R; Aaronson, NK; Brazier, JE; Cella, D; Costa, DSJ; Fayers, PM; Kemmler, G; Peacock, S; Pickard, AS; Rowen, D; Street, DJ; Velikova, G; Young, TA; King, MT
2009-06Validation and calibration of the SF-36 health transition question against an external criterion of clinical change in health status.Knox, SA; King, MT
2009-03-01Validation of modified forms of the PedsQL generic core scales and cancer module scales for adolescents and young adults (AYA) with cancer or a blood disorderEwing, JE; King, MT; Smith, NF
2008-07Validity, responsiveness, and minimal important difference for the SF-6D health utility scale in a spinal cord injured population.Lee, BB; King, MT; Simpson, JM; Haran, MJ; Stockler, MR; Marial, O; Salkeld, G
2006-05-01What influences participation in genetic carrier testing?. Results from a discrete choice experimentHall, J; Fiebig, DG; King, MT; Hossain, I; Louviere, JJ